RxDoctor Payments Data

Erin Lott, PA

Physician Assistant · Charleston, SCNPI 1851621056

Payments from drug & device makers

$8,606in general payments, 2019–2025

Across 382 payments — averaging $22.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Merck$666
  • Johnson & Johnson$486
  • E.r. Squibb & Sons, L.L.C.$426
  • Pfizer$339
  • Takeda Pharmaceuticals U.S.A., Inc.$338
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$8,03093%
  • Education$771%
  • Other$4996%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis37$1,199
Merck29$666
Johnson & Johnson24$486
E.r. Squibb & Sons, L.L.C.24$426
Pfizer19$339
Takeda Pharmaceuticals U.S.A., Inc.11$338
Gilead(2 entities)10$336
Lilly USA, LLC11$265
Sanofi8$221
Array Biopharma Inc14$217
AstraZeneca(2 entities)11$212
Rigel Pharmaceuticals, Inc.9$203
Genentech USA, Inc.10$201
Regeneron Healthcare Solutions, Inc.11$199
AbbVie10$182
Jazz Pharmaceuticals Inc.8$172
Amgen8$169
Seagen Inc.9$157
Incyte Corporation7$151
Karyopharm Therapeutics Inc.7$147
GSK6$146
Eisai Inc.6$137
Bristol Myers Squibb6$119
ADC Therapeutics America, Inc.6$118
Bayer6$109
Servier Pharmaceuticals LLC5$103
Daiichi Sankyo Inc.4$103
Ipsen Biopharmaceuticals, Inc4$87
ASD Specialty Healthcare, LLC1$85
Boehringer Ingelheim3$83
Tersera Therapeutics LLC4$69
Puma Biotechnology, Inc.3$63
Pharmacyclics LLC, An Abbvie Company4$62
Astellas Pharma US Inc2$55
Geron Corporation2$54
Legend Biotech USA Inc.1$51
Taiho Oncology, Inc.3$51
Beigene USA, Inc.2$42
Sobi, Inc2$39
Iovance Biotherapeutics, Inc.1$36
G1 Therapeutics, Inc.2$35
Stemline Therapeutics Inc.1$35
Morphosys, US Inc.2$33
EMD Serono, Inc.2$32
Sumitomo Pharma America, Inc.1$29
Adaptive Biotechnologies Corporation1$28
Secura Bio, Inc.2$27
Pharmacosmos Therapeutics Inc.1$27
Blueprint Medicines Corporation1$26
Pharmaessentia USA Corporation1$26
Acrotech Biopharma Inc.1$25
Fennec Pharmaceuticals, Inc.1$25
Novocure Inc.1$25
Beone Medicines USA, Inc.1$25
Mirati Therapeutics, Inc.1$24
Azurity Pharmaceuticals, Inc.1$24
AVEO Pharmaceuticals, Inc.1$23
Forte Bio-pharma LLC1$23
Genmab U.S., Inc.1$22
Organon1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,606 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$69,721
Medicare patients
270
Services billed
898

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrukinsaZanubrutinib18$254,275
CalquenceAcalabrutinib Maleate14$127,540
EliquisApixaban42$30,542
OrgovyxRelugolix11$29,894
Abiraterone Acetate25$18,544
Anastrozole38$1,412
Letrozole20$496
Tamoxifen Citrate26$485
Acyclovir17$460
Dexamethasone16$364
Olanzapine13$350
Mirtazapine19$276
Prednisone33$131
Potassium Chloride23$126
Ondansetron Hcl16$115

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Beigene USA, Inc.Brukinsa$42$254,27518 claims
AstraZenecaCalquence$212$127,54014 claims
PfizerEliquis$339$30,54242 claims
Sumitomo Pharma America, Inc.Orgovyx$29$29,89411 claims
Lilly USA, LLCOlanzapine$265$35013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →